Effect of clofibrate in non-hemolytic indirect hyperbilirubinemia in full term neonates

Indian Journal of Pediatrics

Volumn 74, Issue 11, 2007, Pages 1003-1006

  Eghbalian, Fatemeh ^a   Pourhossein, Abolfazl ^a   Zandevakili, Hassan ^a  

^a Hormozgan University of Medical Sciences Besat Hospital   (Iran)

Author keywords

Clofibrate; Jaundice; Neonate

Indexed keywords

BILIRUBIN; CLOFIBRATE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXCHANGE BLOOD TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; SEX DIFFERENCE; TREATMENT DURATION;

ANTICHOLESTEREMIC AGENTS; BILIRUBIN; CLOFIBRATE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; PHOTOTHERAPY;

EID: 36949038473     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0184-x     Document Type: Article

References (14)

1. Fanaroff AV, Martin RJ. Neonatal-Perinatal Medicine, 8th ed. St. Louis, USA; Elsevier Mosby; Mosby St. Louis, 2006; 1419-1427.
2. William AH, Ballard RA, Gleason C. Avery's Diseases of the newborn. 8th ed. 2005: 1226-1256.
3. Johnson LH, Brown AK, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of kernicterous. J Pediatr 2002; 140: 386-397.
4. Dennery PA, Seidman D, Stevenson DK. Neonatal Hyperbilirubinemia. NEJM 2001; 344: 581-590.
5. Dennery PA. Pharmacological intervention for the treatment of neonatal jaundice. Semin Neonatal 2002; 7(2): 111-119.
6. Carmona MC, Vinaso MT. Activator of peroxisome proliferators-activated receptor-alpha induce the expression of the uncoupling protein-3 gene expression at birth. Diabetes 1999; 48(6): 1272-1222.
7. Bourget P, Broise I, Desmaris V, Gabilan C. Pharmacokinetics of clofibrate in jaundiced newborn infant at term. Arch Pediatr 1995; 2(8): 722-728.
8. Gordon B. Avery, Mary Ann Fletcher, Mhairi G. Mac Donald. Neonatology: pathophysiology and management of newborns, 5th ed. Lippincott Williams & Wilkins, 1999: 765-820.
9. Lindenbaum A, Hernandorena X, Vial M, Benattar C, Janaud JC, Dehan M et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study. Arch Fr Pediatr 1981; 38: 867-873.
10. Mohammad-Zadeh A, Farhat AS, Iran-pour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr 2005; 72: 123-126.
11. Gabilan JC. Pharmacologic treatment of neonatal jaundice. A new approach. Arch Pediatr 1998; 5(11): 1274-1278.
12. Stem L, Khanna NN, Levy G, Yaffe SJ. Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in new borns. Am J Dis Child 1998; 120: 26-31.
13. Hansen TW. Effect of phenobarbital in bilirubin metabolism rat brain. Biol Neonate 1998; 73: 106-111.
14. Wong RJ, Stevenson DK. Alternative metaloporphyrins for the treatment of neonatal jaundice. J Perinatol 2001; 21: 108-113.